STOCK TITAN

Vanguard disaggregates holdings; affiliates to report separately (IDYA)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Ideaya Biosciences Inc Schedule 13G/A amendment: The Vanguard Group reports 0 shares beneficially owned and 0% of the class. The filing explains that on January 12, 2026 Vanguard underwent an internal realignment and its subsidiaries will report ownership on a disaggregated basis.

The amendment states, in accordance with SEC Release No. 34-39538, that The Vanguard Group, Inc. no longer has beneficial ownership over securities held by those subsidiaries and/or business divisions. Signature is shown by Ashley Grim on March 27, 2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard disaggregation reduces reported parent ownership to zero; subsidiary reporting now appears separate.

The filing shows 0 shares and 0% beneficial ownership for The Vanguard Group after an internal realignment described as effective January 12, 2026. The text cites SEC Release No. 34-39538 and states subsidiaries will report separately.

Implications depend on subsidiary filings; subsequent amendments or separate 13G/A entries by Vanguard affiliates will show the actual holdings. Timing and amounts for those affiliate filings are not included here.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

What did The Vanguard Group report for IDEAYA (IDYA)?

The Vanguard Group reported 0 shares and 0% beneficial ownership. The amendment says Vanguard underwent an internal realignment on January 12, 2026, and will have subsidiaries report ownership separately under SEC Release No. 34-39538.

Why does Vanguard show zero ownership in this 13G/A for IDYA?

Because Vanguard states it completed an internal realignment on January 12, 2026 and will report holdings of former divisions separately. The filing cites SEC Release No. 34-39538 as the basis for disaggregation.

Does this filing disclose how many Ideaya shares Vanguard affiliates hold?

No, this amendment shows The Vanguard Group itself holds 0 shares and 0%. It indicates subsidiaries will report separately; the specific affiliate share counts are not included in this excerpt.

When was the Schedule 13G/A signed and by whom?

The amendment is signed by Ashley Grim, Head of Global Fund Administration, with a signature date of March 27, 2026. The internal realignment referenced occurred on January 12, 2026.

Does the filing state any party has over 5% of IDYA due to Vanguard holdings?

The filing states no one person's interest reported here exceeds 5%. It explains Vanguard, including registered investment companies and managed accounts, have dividend/receipt rights but no single other interest above 5% is identified.
Ideaya Biosciences

NASDAQ:IDYA

View IDYA Stock Overview

IDYA Rankings

IDYA Latest News

IDYA Latest SEC Filings

IDYA Stock Data

2.82B
85.63M
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO